Treatment-related adverse events as predictive biomarkers of efficacy in patients with advanced neuroendocrine tumors treated with surufatinib: results from two phase III studies-Reference-Cited by-同舟云学术

Treatment-related adverse events as predictive biomarkers of efficacy in patients with advanced neuroendocrine tumors treated with surufatinib: results from two phase III studies

Published:2022-04 Issue:2 Volume:7 Page:100453
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Li J.,Cheng Y.,Bai C.,Xu J.,Shen L.,Li J.,Zhou Z.,Li Z.,Chi Y.,Yu X.,Li E.,Xu N.,Liu T.,Lou W.,Bai Y.,Yuan X.,Wang X.,Yuan Y.,Chen J.,Guan S.,Fan S.,Su W.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference19 articles.

1. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States;Dasari;JAMA Oncol,2017

2. ENETS Consensus Guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site;Pavel;Neuroendocrinology,2016

3. Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors;Zhang;Cancer,2007

4. Molecular pathogenesis of neuroendocrine tumors: implications for current and future therapeutic approaches;Oberg;Clin Cancer Res,2013

5. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors;Raymond;N Engl J Med,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine Kinase Inhibitors and Immunotherapy Updates in Neuroendocrine Neoplasms;Best Practice & Research Clinical Endocrinology & Metabolism;2023-09

2. Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy;Cancers;2023-04-28

3. Surufatinib-induced renal thrombotic microangiopathy: first case report and review of literature;Virchows Archiv;2023-04-26

4. Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications;Frontiers in Oncology;2022-08-17